Cargando…
Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy
BACKGROUND: Ewing sarcoma (ES) is sensitive to systemic therapy, including chemotherapy and anti-angiogenesis Tyrosine Kinase Inhibitors(aaTKIs). However, the prognosis of patients with metastatic disease remains poor. Recurrence or distant metastasis after a complete response (CR) or near-CR due to...
Autores principales: | Xu, Jie, Zhi, Xin, Xie, Lu, Sun, Xin, Liu, Xingyu, Liu, Kuisheng, Guo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074284/ https://www.ncbi.nlm.nih.gov/pubmed/35524212 http://dx.doi.org/10.1186/s12885-022-09618-w |
Ejemplares similares
-
Pleural Effusion Revealing a Diagnosis of Ewing Sarcoma
por: Ali, Khaled, et al.
Publicado: (2021) -
Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort, Phase Ib/II Trial
por: Xu, Jie, et al.
Publicado: (2021) -
Extensive marrow infiltration in epidural Ewing sarcoma
por: Mansoori, Huma, et al.
Publicado: (2016) -
Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child
por: Wu, Yang, et al.
Publicado: (2023) -
Radiotherapy for Lung Metastases in a Patient With Ewing Sarcoma
por: Kegye, A., et al.
Publicado: (1998)